---
schema_version: "secwatch.filing_event.v1"
accession: "0001722482-24-000161"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:05:48.618548+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avantor Q3 net sales $1.71B (-0.3%), net income $57.8M, raises FCF guidance

## Summary
- Net sales $1,714.4M, down 0.3% reported; organic decline 0.7%; currency tailwind of 0.4%.
- GAAP diluted EPS $0.08; adjusted EPS $0.26; adjusted EBITDA $302.5M (17.6% margin).
- Lab Solutions sales +1.1% reported (+0.6% organic); Bioscience Production -3.2% (-3.5% organic).
- Operating cash flow $244.8M; free cash flow $204.0M; management raised full-year FCF guidance.
- Adjusted net leverage 3.8x; bioprocessing outperformance and cost programs ahead of plan.

## SEC filing metadata
- accession: 0001722482-24-000161
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000161/0001722482-24-000161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000161/avtr-20241025.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001722482-24-000161
- JSON: https://secwatch.observer/filing/0001722482-24-000161.json
- Plain text: https://secwatch.observer/filing/0001722482-24-000161.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.